MedTrace Logo

Influence of Co-diagnosis of Chronic Fatigue Syndrome in Patients With Fibromyalgia.

NCT05323838 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2023-05-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate differences in neuroimmunoendocrine response and quality of live in patients diagnosed with Fibromyalgia, with or without a co-diagnosis of Chronic Fatigue Syndrome.

Conditions

  • Fibromyalgia
  • Chronic Fatigue Syndrome
  • Comorbidities and Coexisting Conditions

Interventions

BEHAVIORAL

Subjective quality of live

The groups fill out scientifically validated questionnaires to know the differences in perceived stress, anxiety, quality of life, depression, quality of sleep, pain, fatigue, and impact of the disease on daily life.

PROCEDURE

Blood extraction

Blood collection by qualified personnel.

BEHAVIORAL

Accelerometry

To know the objective differences between physical activity/sedentary lifestyle, caloric expenditure and quality of sleep, we used the accelerometry technique

DIETARY_SUPPLEMENT

Synbiotic complement

On two separate days, the "baseline-tests" and "final-tests" were conducted. All participants performed a series of tests, before which they had to fast. The order and schedule (8 am) of the tests was the same for the "final-test" and the same materials and procedures were used. A period of 30 consecutive days elapsed between the base-line and final tests, during which the participants had to ingest their supplement (synbiotic).

Sponsors & Collaborators

  • University of Extremadura

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-09
Primary Completion
2021-06-22
Completion
2024-11-16

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05323838 on ClinicalTrials.gov